Dr. Zoubeidi and her BRN2 publications featured in VCHRI Newsletter

Date Posted: 
2016-11-29

Dr. Amina Zoubeidi is the focus of a Nov. 25 article in the Vancouver Coastal Health Research Institute newsletter.  Read the full article here (opens in new window).

As reported on October 30 this year, a study lead by Dr. Zoubeidi with a team from the Vancouver Prostate Centre and collaborators at Weill Cornell Medicine was published online on October 26, in AACR's journal Cancer Discovery. This publication, titled "The Master Neural Transcription Factor BRN2 is an Androgen Receptor Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer", reports a new potential target for treating/preventing neuroendocrine differentiation in prostate tumours.  This discovery was also published as a Research Highlight in Nature Reviews Urology.

 

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember 2017

Movember 2017

Movember Canada's annual fundraiser for men's health issues, such as prostate cancer, testicular cancer, fitness and mental health, starts November 1st. Visit the  Vancouver Prostate Centre's fundraising page to donate to or join our team.

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.